Trazher
HER2‑positive breast cancer
CommercialActive
Key Facts
About Innogene Kalbiotech
Asian‑focused biotech delivering oncology biologics, biosimilars, and precision diagnostics across ASEAN.
View full company profileTherapeutic Areas
Other HER2‑positive breast cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Herceptin (Trastuzumab) Biosimilar | NeuClone | Phase 1 |
| Perjeta (Pertuzumab) Biosimilar | NeuClone | Process Scale‑up |
| MagSense™ HER2 Imaging Agent | Imagion Biosystems | Phase 2 |
| P-003 | Panacea Biotec | Phase 3 |
| Trastuzumab Biosimilar | Hetero | Phase 3 |
| Legrand‑Herceptin Biosimilar | Laboratorios Legrand | Commercial |
| AfriMab-1 | Afrigen Biologics | Preclinical |
| Biosimilar Trastuzumab | Biosidus | Commercial |
| MINC‑trastuzumab | Suntec Medical | Preclinical |